UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000033228 |
|---|---|
| Receipt number | R000037889 |
| Scientific Title | Association of Lecithin-cholesterol Acyltransferase Activity and Low-density Lipoprotein Heterogeneity with Atherosclerotic Cardiovascular Risk: A Pilot Longitudinal Study |
| Date of disclosure of the study information | 2018/07/02 |
| Last modified on | 2018/12/10 06:49:14 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Association of Lecithin-cholesterol Acyltransferase Activity and Low-density Lipoprotein Heterogeneity with Atherosclerotic Cardiovascular Risk: A Pilot Longitudinal Study
Acronym
LCAT activity and LDL-particle size
Scientific Title
Association of Lecithin-cholesterol Acyltransferase Activity and Low-density Lipoprotein Heterogeneity with Atherosclerotic Cardiovascular Risk: A Pilot Longitudinal Study
Scientific Title:Acronym
LCAT activity and LDL-particle size
Region
| Japan |
Condition
Condition
The criterion for patient registration was the presence of one or more risk factors for atherosclerosis.
Classification by specialty
| Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study was designed as a hospital-based longitudinal study to investigate the relationship between the change in LCAT activity and change in LDL-particle size in subjects who were available for additional measurements one year after their participation in our previous study.
Basic objectives2
Others
Basic objectives -Others
using a longitudinal study, we attempted to clarify hypothesis that elevation of LCAT activity is associated with an increase in the serum levels of TRL-related markers, involved in TG metabolism (i.e. TG, remnant particle-like cholesterol [RLP-C], apolipoprotein (apo) B, apo C-2, and apo C-3), and is thus involved in reduction of the LDL-particle size.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The primary endo point was to evaluate the association of the absolute change in
LCAT activity with the change in LDL particle size, using a multilogistic
regression analysis
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | > |
Gender
Male and Female
Key inclusion criteria
The criterion for patient registration was the presence of one or more risk factors for atherosclerosis.
Key exclusion criteria
hepatic dysfunction (alanine aminotransferase and aspartate aminotransferase more than 2 times the upper limit of the normal values), known malignant disease, refusal to provide consent for participation in the study, or the diagnosis of acute coronary syndrome within 3 months prior to the study, and/or serum TG 400 mg/dL.
Target sample size
400
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Shigemasa Tani |
Organization
Nihon University Hospital
Division name
Department of Cardiology
Zip code
Address
1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo , Japan
TEL
03-3293-1711
tanishigem@yahoo.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Shigemasa Tani |
Organization
Nihon University Hospital
Division name
Department of Cardiology
Zip code
Address
1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo , Japan
TEL
03-3293-1711
Homepage URL
tanishigem@yahoo.co.jp
Sponsor or person
Institute
Department of Cardiology, Nihon University Hospital
Institute
Department
Personal name
Funding Source
Organization
Department of Cardiology, Nihon University Hospital
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 07 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 04 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2018 | Year | 07 | Month | 02 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Collecting patient data.
Management information
Registered date
| 2018 | Year | 07 | Month | 02 | Day |
Last modified on
| 2018 | Year | 12 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037889
